Data / Form D filings / MindImmune Therapeutics, Inc.
MindImmune Therapeutics, Inc.: Form D filings
MindImmune Therapeutics, Inc., a pharmaceuticals company in Kingston, RI, filed 4 Form D notices with the SEC between 2019 and 2026. The latest, on March 5, 2026, reports $15.2 million sold of a $17 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 130 FLAGG ROAD, Kingston, RI, 02881
- Phone
- (401) 225-4612
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1792522
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Amendment | $17,014,485 | $15,218,343 | $1,796,142 | 15 | Nov 24, 2025 | sec.gov |
| Dec 5, 2025 | New notice | $12,000,000 | $10,203,858 | $1,796,142 | 14 | Nov 24, 2025 | sec.gov |
| Feb 4, 2022 | New notice | $8,880,000 | $5,349,999 | $3,530,001 | 12 | Jan 25, 2022 | sec.gov |
| Nov 1, 2019 | New notice | $3,000,000 | $750,000 | $2,250,000 | 8 | Oct 22, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Isaac Stoner | Executive Officer, Director | CEO |
| Bradley Margus | Director | |
| Christopher O'Donnell | Director | |
| Reetika Bhardwaj | Director |
Every Form D from the week of Mar 2, 2026 · All recent filings in Rhode Island · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MindImmune Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.